MORRIS PLAINS, N.J., May 29, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at Jefferies 2012 Global Healthcare Conference at 1:30 p.m. on Tuesday, June 5, 2012, in New York City. The presentation, which can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf, will provide a corporate overview.
